E
ENEAPHARM
The startup develops drug formulations specifically designed to treat pancreatic diseases by enhancing the effectiveness of existing therapies and restoring digestive assimilation functions. This approach aims to improve patient care quality and life without the side effects commonly associated with current treatment options.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$400KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops drug formulations specifically designed to treat pancreatic diseases by enhancing the effectiveness of existing therapies and restoring digestive assimilation functions. This approach aims to improve patient care quality and life without the side effects commonly associated with current treatment options.